Literature DB >> 324763

Isolation, purification and properties of an intermediate in 3-deoxy-D-manno-octulosonic acid--lipid A biosynthesis.

V Lehmann.   

Abstract

Incomplete lipid A has been purified from a mutant of Salmonella typhimurium which is temperature-sensitive both in synthesis of 3-deoxy-D-manno-octulosonic acid 8-phosphate (dOclA-8-P) and in growth. Pulse-chase experiments have shown that the incomplete lipid A molecule is the intermediate in the biosynthesis of the dOclA-lipid A portion of lipopolysaccharides. The purification procedure included DEAE-cellulose chromatography and electrodialysis. A highly water-soluble precursor material was obtained, consisting of glucosamine, phosphate and 3-hydroxymyristic acid in a molar ratio of 1:1.2:2.1. Labeling experiments as well as chemical degradation procedures revealed the precursor molecule to be composed of a diphosphorylated glucosamine-disaccharide carrying two amide-linked and two ester-linked 3-hydroxymyristic acids. In contrast to the complete dOclA-lipid A part, the intermediate lacks 3-deoxy-D-manno-octulosonic acid as well as nonhydroxylated fatty acids. On the basis of these findings a pathway for the final steps in dOclA-lipid A biosynthesis is proposed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324763     DOI: 10.1111/j.1432-1033.1977.tb11525.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A.

Authors:  S Kotani; H Takada; M Tsujimoto; T Ogawa; K Harada; Y Mori; A Kawasaki; A Tanaka; S Nagao; S Tanaka
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

2.  Chemical structure and biological activities of lipid A's from various bacterial families.

Authors:  O Lüderitz; C Galanos; V Lehmann; H Mayer; E T Rietschel; J Weckesser
Journal:  Naturwissenschaften       Date:  1978-11

3.  Inhibition of exogenous 3-deoxy-D-manno-octulosonate incorporation into lipid A precursor of toluene-treated Salmonella typhimurium cells.

Authors:  J O Capobianco; R P Darveau; R C Goldman; P A Lartey; A G Pernet
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

4.  Isolation and structural analysis of two lipid A precursors from a KDO deficient mutant of Salmonella typhimurium differing in their hexadecanoic acid content.

Authors:  T Hansen-Hagge; V Lehmann; U Seydel; B Lindner; U Zähringer
Journal:  Arch Microbiol       Date:  1985-05       Impact factor: 2.552

5.  Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.

Authors:  S Kotani; H Takada; M Tsujimoto; T Ogawa; I Takahashi; T Ikeda; K Otsuka; H Shimauchi; N Kasai; J Mashimo
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

6.  Relationship between cell death and altered lipid A synthesis in a temperature-sensitive lethal mutant of Salmonella typhimurium that is conditionally defective in 3-deoxy-D-manno-octulosonate-8-phosphate synthesis.

Authors:  P D Rick; D A Young
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

7.  Isolation and characterization of a temperature-sensitive lethal mutant of Salmonella typhimurium that is conditionally defective in 3-deoxy-D-manno-octulosonate-8-phosphate synthesis.

Authors:  P D Rick; D A Young
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

8.  Selective induction of metabolic activation programs in peritoneal macrophages by lipopolysaccharide substructures.

Authors:  V Lehmann; B Benninghoff; W Dröge
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Two interacting mutations causing temperature-sensitive phosphatidylglycerol synthesis in Escherichia coli membranes.

Authors:  M Nishijima; C E Bulawa; C R Raetz
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

10.  Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs.

Authors:  H Takada; S Kotani; M Tsujimoto; T Ogawa; I Takahashi; K Harada; C Katsukawa; S Tanaka; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.